These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26456145)

  • 1. Osteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methods.
    Evans HR; Karmakharm T; Lawson MA; Walker RE; Harris W; Fellows C; Huggins ID; Richmond P; Chantry AD
    Bone; 2016 Feb; 83():9-16. PubMed ID: 26456145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the Progression of Osteolytic and Osteosclerotic Lesions in Mice Using Serial In Vivo μCT: Applications to the Assessment of Bisphosphonate Treatment Efficacy.
    Campbell GM; Tower RJ; Damm T; Kneissl P; Rambow AC; Schem C; Tiwari S; Glüer CC
    J Bone Miner Res; 2018 Mar; 33(3):410-418. PubMed ID: 29044710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalized volume of interest selection and measurement of bone volume in microCT scans.
    Snoeks TJ; Kaijzel EL; Que I; Mol IM; Löwik CW; Dijkstra J
    Bone; 2011 Dec; 49(6):1264-9. PubMed ID: 21945738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated bone volume and thickness measurements in small animal whole-body MicroCT data.
    Baiker M; Snoeks TJ; Kaijzel EL; Que I; Dijkstra J; Lelieveldt BP; Löwik CW
    Mol Imaging Biol; 2012 Aug; 14(4):420-30. PubMed ID: 21993834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis.
    Arrington SA; Schoonmaker JE; Damron TA; Mann KA; Allen MJ
    Bone; 2006 Mar; 38(3):359-67. PubMed ID: 16278105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ex vivo micro-computed tomography for assessment of in vivo fluorescence and plain radiographic imaging for monitoring bone metastases and osteolytic lesions.
    Tiwari S; Schem C; Lorenzen AC; Kayser O; Wiese C; Graeff C; Peña J; Marshall RP; Heller M; Kalthoff H; Jonat W; Glüer CC
    J Bone Miner Metab; 2012 May; 30(3):373-80. PubMed ID: 22130787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.
    Lawson MA; Paton-Hough JM; Evans HR; Walker RE; Harris W; Ratnabalan D; Snowden JA; Chantry AD
    PLoS One; 2015; 10(3):e0119546. PubMed ID: 25768011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.
    Missbach-Guentner J; Dullin C; Zientkowska M; Domeyer-Missbach M; Kimmina S; Obenauer S; Kauer F; Stühmer W; Grabbe E; Vogel WF; Alves F
    Neoplasia; 2007 Sep; 9(9):755-65. PubMed ID: 17898871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantification strategy for missing bone mass in case of osteolytic bone lesions.
    Fränzle A; Bretschi M; Bäuerle T; Giske K; Hillengass J; Bendl R
    Med Phys; 2013 Dec; 40(12):123501. PubMed ID: 24320541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model.
    Lynch ME; Brooks D; Mohanan S; Lee MJ; Polamraju P; Dent K; Bonassar LJ; van der Meulen MC; Fischbach C
    J Bone Miner Res; 2013 Nov; 28(11):2357-67. PubMed ID: 23649605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
    Feeley BT; Liu NQ; Conduah AH; Krenek L; Roth K; Dougall WC; Huard J; Dubinett S; Lieberman JR
    J Bone Miner Res; 2006 Oct; 21(10):1571-80. PubMed ID: 16995812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
    Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
    Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.
    Virk MS; Petrigliano FA; Liu NQ; Chatziioannou AF; Stout D; Kang CO; Dougall WC; Lieberman JR
    Bone; 2009 Jan; 44(1):160-7. PubMed ID: 18929692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle-induced osteolysis in three-dimensional micro-computed tomography.
    Wedemeyer C; Xu J; Neuerburg C; Landgraeber S; Malyar NM; von Knoch F; Gosheger G; von Knoch M; Löer F; Saxler G
    Calcif Tissue Int; 2007 Nov; 81(5):394-402. PubMed ID: 17952672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess TGF-β mediates muscle weakness associated with bone metastases in mice.
    Waning DL; Mohammad KS; Reiken S; Xie W; Andersson DC; John S; Chiechi A; Wright LE; Umanskaya A; Niewolna M; Trivedi T; Charkhzarrin S; Khatiwada P; Wronska A; Haynes A; Benassi MS; Witzmann FA; Zhen G; Wang X; Cao X; Roodman GD; Marks AR; Guise TA
    Nat Med; 2015 Nov; 21(11):1262-1271. PubMed ID: 26457758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation.
    Young SAE; Heller AD; Garske DS; Rummler M; Qian V; Ellinghaus A; Duda GN; Willie BM; Grüneboom A; Cipitria A
    Sci Adv; 2024 Feb; 10(8):eadj0975. PubMed ID: 38381833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor-induced osteolysis.
    Kurth AH; Wang C; Hayes WC; Shea M
    J Orthop Res; 2001 Mar; 19(2):200-5. PubMed ID: 11347691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy.
    Chappard D; Libouban H; Legrand E; Ifrah N; Masson C; Baslé MF; Audran M
    Anat Rec (Hoboken); 2010 Jul; 293(7):1125-33. PubMed ID: 20583257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.